Global Next Generation Sequencing (NGS) Competitive Landscape Professional Research Report 2025
Research SummaryNext Generation Sequencing (NGS), also known as high-throughput sequencing, is a powerful and advanced technology used for DNA and RNA sequencing. It enables rapid and cost-effective sequencing of large amounts of genetic material, providing researchers with comprehensive and detailed insights into the genetic makeup of organisms. NGS techniques have revolutionized genomics research and have numerous applications in various fields such as biomedical research, agriculture, evolutionary biology, and personalized medicine. NGS platforms utilize innovative sequencing technologies, such as Illumina sequencing, Ion Torrent sequencing, and PacBio sequencing, to generate vast amounts of sequence data in parallel, allowing for the analysis of whole genomes, targeted gene sequencing, transcriptomics, epigenetics, and metagenomics. NGS has significantly accelerated the pace of scientific discoveries, enabling the identification of disease-causing variants, understanding genetic diversity, studying gene expression patterns, and unraveling complex molecular interactions.
According to DIResearch's in-depth investigation and research, the global Next Generation Sequencing (NGS) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Next Generation Sequencing (NGS) include Illumina, Thermo Fisher Scientific, BGI, LabCorp, Roche, PerkinElmer, New England Biolabs, Eurofins Scientific, Mgi Tech, Agilent Technologies, Promega, Natera, Norgen Biotek, LifeCodexx, Amoy Diagnostics, BioCat GmbH, CoWin Biotech, Berrygenomics, Rightongene Biotechnology, Kindstar Global, Capitalbio, QIAGEN, Annaroad Gene Technology, Find Biotechnology, Daan Gene, Omixon, Novogene, Swift Biosciences, NimaGen etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Next Generation Sequencing (NGS). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Next Generation Sequencing (NGS) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Next Generation Sequencing (NGS) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Next Generation Sequencing (NGS) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Next Generation Sequencing (NGS) Include:
Illumina
Thermo Fisher Scientific
BGI
LabCorp
Roche
PerkinElmer
New England Biolabs
Eurofins Scientific
Mgi Tech
Agilent Technologies
Promega
Natera
Norgen Biotek
LifeCodexx
Amoy Diagnostics
BioCat GmbH
CoWin Biotech
Berrygenomics
Rightongene Biotechnology
Kindstar Global
Capitalbio
QIAGEN
Annaroad Gene Technology
Find Biotechnology
Daan Gene
Omixon
Novogene
Swift Biosciences
NimaGen
Next Generation Sequencing (NGS) Product Segment Include:
Consumables and Reagents
Instruments
Others
Next Generation Sequencing (NGS) Product Application Include:
Life Science
Traslational Medicine & Pharma
Others
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Next Generation Sequencing (NGS) Industry PESTEL Analysis
Chapter 3: Global Next Generation Sequencing (NGS) Industry Porter’s Five Forces Analysis
Chapter 4: Global Next Generation Sequencing (NGS) Major Regional Market Size and Forecast Analysis
Chapter 5: Global Next Generation Sequencing (NGS) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Next Generation Sequencing (NGS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Next Generation Sequencing (NGS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Next Generation Sequencing (NGS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Next Generation Sequencing (NGS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Next Generation Sequencing (NGS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Next Generation Sequencing (NGS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Next Generation Sequencing (NGS) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources